Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Sep;76(3):937–946. doi: 10.1172/JCI112093

Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.

G J Broze Jr, S Hickman, J P Miletich
PMCID: PMC423957  PMID: 2995451

Abstract

Several murine monoclonal anti-human Factor VII antibodies were produced using hybridoma technology. Two noncompetitive monoclonal antibodies were used to examine by Western blotting the Factor VII cross-reactive material (CRM) in normal human plasma and three commercially available congenitally Factor VII-deficient plasmas, and to construct a facile "sandwich" immunoassay for plasma Factor VII. A second, previously undescribed, form of Factor VII CRM was detected in human plasma, which on Western blotting stained with an apparent intensity 5-8% that of Factor VII. This glycoprotein, tentatively called VII*, has a molecular weight 4,500 D less than Factor VII, lacks detectable Factor VII functional activity, does not bind to barium citrate, and is not recognized by a monoclonal antibody that recognizes Factor VII but not alpha-chymotrypsin-treated Factor VII. VII* was not proteolytically produced from Factor VII during in vitro coagulation or after infusion of human Factor VII into rabbits. As determined by Western blotting, the human hepatoma cell line, HepG2, cultured in the presence of vitamin K, secreted relatively greater levels of VII* in proportion to VII (75%) than that found in human plasma. Warfarin treatment of HepG2 cells decreased the quantity of VII secreted by 77%, whereas it only inhibited the secretion of VII* by 14%. Immunologic studies of the plasmas from a patient on chronic warfarin therapy and an individual given a short course of high dose warfarin therapy corroborated the in vitro synthetic studies obtained with HepG2 cells. The data are consistent with the production of VII* by posttranslational, proteolytic, modification of VII, that, at least in the HepG2 cells studied, occurs intracellularly. However, other mechanisms for the production of VII*, in particular, alternative RNA splicing of the transcript from a single gene, cannot be excluded.

Full text

PDF
937

Images in this article

940Image
on p.940
941Image
on p.941
941Image
on p.941
942Image
on p.942
942Image
on p.942
943Image
on p.943
943Image
on p.943
944Image
on p.944

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajaj S. P., Rapaport S. I., Brown S. F. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem. 1981 Jan 10;256(1):253–259. [PubMed] [Google Scholar]
  2. Bertina R. M., Westhoek-Kuipers M. E., Alderkamp G. H. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment. Thromb Haemost. 1981 Jun 30;45(3):237–241. [PubMed] [Google Scholar]
  3. Broze G. J., Jr Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982 Sep;70(3):526–535. doi: 10.1172/JCI110644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broze G. J., Jr, Majerus P. W. Purification and properties of human coagulation factor VII. J Biol Chem. 1980 Feb 25;255(4):1242–1247. [PubMed] [Google Scholar]
  5. Dode C., Rabiet M. J., Bertrand O., Labie D., Elion J. Characterization of a proteolytically modified form of human prothorombin. Biochem Biophys Res Commun. 1980 May 30;94(2):660–666. doi: 10.1016/0006-291x(80)91283-8. [DOI] [PubMed] [Google Scholar]
  6. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971 Sep;8(9):871–874. doi: 10.1016/0019-2791(71)90454-x. [DOI] [PubMed] [Google Scholar]
  7. Esmon C. T., Suttie J. W., Jackson C. M. The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. J Biol Chem. 1975 Jun 10;250(11):4095–4099. [PubMed] [Google Scholar]
  8. Esmon N. L., DeBault L. E., Esmon C. T. Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. J Biol Chem. 1983 May 10;258(9):5548–5553. [PubMed] [Google Scholar]
  9. Fair D. S., Bahnak B. R. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood. 1984 Jul;64(1):194–204. [PubMed] [Google Scholar]
  10. Fair D. S. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood. 1983 Oct;62(4):784–791. [PubMed] [Google Scholar]
  11. GODAL H. C., MADSEN K., MEYER R. N. Thrombo-embolism in patients with total proconvertin (factor VII) deficency. A report on two cases. Acta Med Scand. 1962 Mar;171:325–327. [PubMed] [Google Scholar]
  12. Galfrè G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. doi: 10.1016/0076-6879(81)73054-4. [DOI] [PubMed] [Google Scholar]
  13. Gershwin M. E., Gude J. K. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med. 1973 Jan 18;288(3):141–142. doi: 10.1056/NEJM197301182880309. [DOI] [PubMed] [Google Scholar]
  14. Girolami A., Cattarozzi G., Dal Bo Zanon R., Toffanin F. Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. Blood. 1979 Jul;54(1):46–53. [PubMed] [Google Scholar]
  15. Girolami A., Fabris F., Dal Bo Zanon R., Ghiotto G., Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med. 1978 Mar;91(3):387–395. [PubMed] [Google Scholar]
  16. Girolami A., Falezza G., Patrassi G., Stenico M., Vettore L. Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency. Blood. 1977 Oct;50(4):603–610. [PubMed] [Google Scholar]
  17. HALL C. A., RAPAPORT S. I., AMES S. B., DEGROOT J. A. A CLINICAL AND FAMILY STUDY OF HEREDITARY PROCONVERTIN (FACTOR VII) DEFICIENCY. Am J Med. 1964 Aug;37:172–181. doi: 10.1016/0002-9343(64)90003-8. [DOI] [PubMed] [Google Scholar]
  18. Howarth D. J., Brozović M., Stirling Y., Reed M. Factor VII during warfarin treatment. Scand J Haematol. 1974;12(5):346–354. doi: 10.1111/j.1600-0609.1974.tb00220.x. [DOI] [PubMed] [Google Scholar]
  19. Hubbard S. C., Ivatt R. J. Synthesis and processing of asparagine-linked oligosaccharides. Annu Rev Biochem. 1981;50:555–583. doi: 10.1146/annurev.bi.50.070181.003011. [DOI] [PubMed] [Google Scholar]
  20. Kitamura N., Takagaki Y., Furuto S., Tanaka T., Nawa H., Nakanishi S. A single gene for bovine high molecular weight and low molecular weight kininogens. Nature. 1983 Oct 6;305(5934):545–549. doi: 10.1038/305545a0. [DOI] [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Mariani G., Mazzucconi M. G. Factor VII congenital deficiency. Clinical picture and classification of the variants. Haemostasis. 1983;13(3):169–177. doi: 10.1159/000214723. [DOI] [PubMed] [Google Scholar]
  23. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J Biol Chem. 1978 Oct 10;253(19):6908–6916. [PubMed] [Google Scholar]
  24. Nawa H., Kotani H., Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984 Dec 20;312(5996):729–734. doi: 10.1038/312729a0. [DOI] [PubMed] [Google Scholar]
  25. Nelsestuen G. L., Suttie J. W. The purification and properties of an abnormal prothrombin protein produced by dicumarol-treated cows. A comparison to normal prothrombin. J Biol Chem. 1972 Dec 25;247(24):8176–8182. [PubMed] [Google Scholar]
  26. Nelsestuen G. L., Zytkovicz T. H., Howard J. B. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem. 1974 Oct 10;249(19):6347–6350. [PubMed] [Google Scholar]
  27. Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry. 1966 Feb;5(2):601–608. doi: 10.1021/bi00866a029. [DOI] [PubMed] [Google Scholar]
  28. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Radcliffe R., Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975 Jan 25;250(2):388–395. [PubMed] [Google Scholar]
  30. Ragni M. V., Lewis J. H., Spero J. A., Hasiba U. Factor VII deficiency. Am J Hematol. 1981;10(1):79–88. doi: 10.1002/ajh.2830100112. [DOI] [PubMed] [Google Scholar]
  31. Robert B., Daubas P., Akimenko M. A., Cohen A., Garner I., Guenet J. L., Buckingham M. A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell. 1984 Nov;39(1):129–140. doi: 10.1016/0092-8674(84)90198-3. [DOI] [PubMed] [Google Scholar]
  32. Stenflo J., Fernlund P., Egan W., Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2730–2733. doi: 10.1073/pnas.71.7.2730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tamkun J. W., Schwarzbauer J. E., Hynes R. O. A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5140–5144. doi: 10.1073/pnas.81.16.5140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tarentino A. L., Trimble R. B., Maley F. endo-beta-N-Acetylglucosaminidase from Streptomyces plicatus. Methods Enzymol. 1978;50:574–580. doi: 10.1016/0076-6879(78)50065-7. [DOI] [PubMed] [Google Scholar]
  35. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zur M., Radcliffe R. D., Oberdick J., Nemerson Y. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen. J Biol Chem. 1982 May 25;257(10):5623–5631. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES